Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

To SEC-MALS & Beyond - The Road to Biotherapeutic Development Illuminated by Light Scattering

01 Oct 2013 - 01 Oct 2013 - Online Webinar

Bookmark and Share

We present HPLC/SEC-MALS, the technique for quantifying absolute molecular weight, size, polydispersity, aggregation and degree of conjugation. Developers of biopharmaceuticals rely on Wyatt Technology's SEC-MALS products to navigate the path to drug product with confidence.  We review how the Wyatt light scattering instruments constitute a unique set of orthogonal and complementary methods alongside SEC-MALS: SEC-DLS for size & conformation; FFF-MALS for separation & characterization; CG-MALS for intermolecular interactions, and microwell plate-based DLS for high-throughput screening.

Who should attend:
• Researchers assessing biomolecular quality, including size and concentration of aggregates, degree of polymer conjugation, and column interactions
• Protein chemists optimizing production, modification, and formulation of biotherapeutic lead molecules
• Laboratory Managers/Directors/Supervisors performing biophysical characterization

Questions to be answered:
• How do MALS and DLS increase the chromatography data value for advanced analysis of IgG, ADCs, PEGylated proteins, and new format biotherapeutics?
• How can batch light scattering contribute to assessing stability and developing robust formulations?

Further information
Scientific News
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Four Gut Bacteria Decrease Asthma Risk in Infants
New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos